Logo image of JMAC

MAXPRO CAPITAL ACQUISITION-A (JMAC) Stock Overview

USA - NASDAQ:JMAC - US57778T1060 - Common Stock

10.81 USD
-0.71 (-6.16%)
Last: 3/29/2023, 8:16:08 PM
10.73 USD
-0.08 (-0.74%)
After Hours: 3/29/2023, 8:16:08 PM

JMAC Key Statistics, Chart & Performance

Key Statistics
Market Cap145.15M
Revenue(TTM)N/A
Net Income(TTM)-823160
Shares13.43M
Float9.86M
52 Week High19.22
52 Week Low7.5
Yearly Dividend0.3
Dividend Yield1.26%
EPS(TTM)-0.08
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2021-10-08
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


JMAC short term performance overview.The bars show the price performance of JMAC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15 -20

JMAC long term performance overview.The bars show the price performance of JMAC in the last 1, 2 and 3 years. 1 year 2 years 3 years 2 4 6 8

The current stock price of JMAC is 10.81 USD. In the past month the price increased by 3.05%. In the past year, price increased by 8.64%.

MAXPRO CAPITAL ACQUISITION-A / JMAC Daily stock chart

JMAC Latest News, Press Relases and Analysis

About JMAC

Company Profile

Maxpro Capital Acquisition Corp. operates as a blank check company. The company is headquartered in Taipei City, Taipei. The company went IPO on 2021-10-08. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm's acquisitions are focused on companies in the healthcare technology sector in which its management team has experiences. The firm plans to explore industries include, but are not limited to, the healthcare and technology industries, particularly in the biotechnology and pharmaceutical industries.

Company Info

MAXPRO CAPITAL ACQUISITION-A

5F-4, No. 89, Songren Road, Xinyi District

Taipei City TAIPEI TW

Employees: 0

Phone: 88620771307952.0

MAXPRO CAPITAL ACQUISITION-A / JMAC FAQ

What does JMAC do?

Maxpro Capital Acquisition Corp. operates as a blank check company. The company is headquartered in Taipei City, Taipei. The company went IPO on 2021-10-08. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm's acquisitions are focused on companies in the healthcare technology sector in which its management team has experiences. The firm plans to explore industries include, but are not limited to, the healthcare and technology industries, particularly in the biotechnology and pharmaceutical industries.


Can you provide the latest stock price for MAXPRO CAPITAL ACQUISITION-A?

The current stock price of JMAC is 10.81 USD. The price decreased by -6.16% in the last trading session.


Does JMAC stock pay dividends?

MAXPRO CAPITAL ACQUISITION-A (JMAC) has a dividend yield of 1.26%. The yearly dividend amount is currently 0.3.


What is the ChartMill technical and fundamental rating of JMAC stock?

JMAC has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the PE ratio for JMAC stock?

MAXPRO CAPITAL ACQUISITION-A (JMAC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).


What is the market capitalization of JMAC stock?

MAXPRO CAPITAL ACQUISITION-A (JMAC) has a market capitalization of 145.15M USD. This makes JMAC a Micro Cap stock.


JMAC Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to JMAC. When comparing the yearly performance of all stocks, JMAC is one of the better performing stocks in the market, outperforming 86.76% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

JMAC Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to JMAC. JMAC has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

JMAC Financial Highlights

Over the last trailing twelve months JMAC reported a non-GAAP Earnings per Share(EPS) of -0.08.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-1224.24%
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

JMAC Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

JMAC Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A